2021
Linking criminal justice-involved individuals to HIV, Hepatitis C, and opioid use disorder prevention and treatment services upon release to the community: Progress, gaps, and future directions
Taweh N, Schlossberg E, Frank C, Nijhawan A, Kuo I, Knight K, Springer SA. Linking criminal justice-involved individuals to HIV, Hepatitis C, and opioid use disorder prevention and treatment services upon release to the community: Progress, gaps, and future directions. International Journal Of Drug Policy 2021, 96: 103283. PMID: 34020864, PMCID: PMC8568621, DOI: 10.1016/j.drugpo.2021.103283.Peer-Reviewed Original ResearchConceptsMobile health unitOpioid use disorderHepatitis COUD preventionTreatment servicesInfectious diseasesHepatitis C virus (HCV) managementOpioid use disorder preventionCJ-involved individualsCriminal justice-involved individualsCJ systemHarm reduction servicesImproving HIVCare cascadePatient navigationJustice-involved individualsHealth unitsUse disordersHIVReduction servicesSubstance usePreventionDisorder preventionCommunity agenciesTreatment
2020
Preventing HIV outbreaks among people who inject drugs in the United States: plus ça change, plus ça même chose.
Strathdee SA, Kuo I, El-Bassel N, Hodder S, Smith LR, Springer SA. Preventing HIV outbreaks among people who inject drugs in the United States: plus ça change, plus ça même chose. AIDS 2020, 34: 1997-2005. PMID: 32826391, PMCID: PMC7606503, DOI: 10.1097/qad.0000000000002673.Peer-Reviewed Original ResearchConceptsHIV outbreakRecent HIV outbreaksEpidemiology of HIVEvidence-based interventionsOpioid disordersHIV infectionTreatment cascadeEvidence-based responsesHIV epidemicOpioid epidemicHIV preventionPrescription opiatesHIVPWIDSynthetic opioidsDrugsPublic healthInfectionPreventionHigher proportionUnited StatesEpidemicOutbreakEditorial reviewRelentless cycle
2017
Patient preferences and extended-release naltrexone: A new opportunity to treat opioid use disorders in Ukraine
Marcus R, Makarenko I, Mazhnaya A, Zelenev A, Polonsky M, Madden L, Filippovych S, Dvoriak S, Springer SA, Altice FL. Patient preferences and extended-release naltrexone: A new opportunity to treat opioid use disorders in Ukraine. Drug And Alcohol Dependence 2017, 179: 213-219. PMID: 28806638, PMCID: PMC5599372, DOI: 10.1016/j.drugalcdep.2017.07.010.Peer-Reviewed Original ResearchConceptsOpioid agonist therapyOpioid use disorderExtended-release naltrexoneXR-NTXHIV preventionIndependent correlatesPatient preferencesUse disordersShort-term injectorsPatient-centered treatmentAgonist therapyPharmacological therapyHIV incidenceTreatment optionsPWIDTreatment entryAddiction treatmentPreventionNaltrexoneShort durationTherapyNegative attitudesDisordersNew optionsTreatment
2011
Advances in the prevention of heterosexual transmission of HIV/AIDS among women in the United States
Chen N, Meyer J, Springer S. Advances in the prevention of heterosexual transmission of HIV/AIDS among women in the United States. Infectious Disease Reports 2011, 3: 6. DOI: 10.4081/idr.2011.2362.Peer-Reviewed Original ResearchHIV/AIDSHeterosexual transmissionVaginal pre-exposure prophylaxisSpecific high-risk groupsPre-exposure prophylaxisHigh-risk groupNon-Hispanic blacksHistory of incarcerationHIV transmissionBiologic susceptibilityVaginal microbicidesHIV preventionFemale condomNew infectionsU.S. womenMale partnersWomenIntimate partner violenceImportance of advocacyAIDSCondomsVulnerability of womenPreventionInterventionPartner violenceAdvances in the prevention of heterosexual transmission of HIV/AIDS among women in the United States
Chen NE, Meyer JP, Springer SA. Advances in the prevention of heterosexual transmission of HIV/AIDS among women in the United States. Infectious Disease Reports 2011, 3: e6. PMID: 23745166, PMCID: PMC3671603, DOI: 10.4081/idr.2011.e6.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsHIV/AIDSHeterosexual transmissionVaginal pre-exposure prophylaxisSpecific high-risk groupsPre-exposure prophylaxisHigh-risk groupNon-Hispanic blacksHistory of incarcerationHIV transmissionBiologic susceptibilityVaginal microbicidesHIV preventionFemale condomNew infectionsU.S. womenMale partnersWomenIntimate partner violenceImportance of advocacyAIDSCondomsVulnerability of womenPreventionInterventionPartner violence
2010
Commentary on Larney (2010): A call to action—opioid substitution therapy as a conduit to routine care and primary prevention of HIV transmission among opioid‐dependent prisoners
Springer SA. Commentary on Larney (2010): A call to action—opioid substitution therapy as a conduit to routine care and primary prevention of HIV transmission among opioid‐dependent prisoners. Addiction 2010, 105: 224-225. PMID: 20078481, PMCID: PMC2825564, DOI: 10.1111/j.1360-0443.2009.02893.x.Peer-Reviewed Original Research